| Price | 9.35p on 15-04-2026 at 07:01:45 |
|---|---|
| Change | -0.01p -0.11% |
| Buy | 9.50p |
| Sell | 9.20p |
| Last Trade: | Sell 10,672.00 at 9.3325p |
| Day's Volume: | 10,672 |
| Last Close: | 9.36p |
| Open: | 9.35p |
| ISIN: | GB00BYV81293 |
| Day's Range | 9.35p - 9.35p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £99.90m |
| VWAP: | 9.3325p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 10,672 | 9.3325p | Ordinary |
08:01:42 - 15-Apr-26 |
| Unknown* | 500,000 | 9.00p | Ordinary |
16:35:48 - 14-Apr-26 |
| Unknown* | 1,000,000 | 9.00p | Ordinary |
16:35:38 - 14-Apr-26 |
| Buy* | 6,427 | 9.36p | Suspected BUY Trade |
16:35:22 - 14-Apr-26 |
| Sell* | 3,500 | 9.3325p | Ordinary |
16:17:14 - 14-Apr-26 |
| Sell* | 28,665 | 9.278p | Ordinary |
16:01:42 - 14-Apr-26 |
| Buy* | 150 | 9.50p | SI Trade |
16:00:29 - 14-Apr-26 |
| Sell* | 13 | 9.20p | SI Trade |
16:00:29 - 14-Apr-26 |
| Sell* | 267 | 9.20p | SI Trade |
16:00:29 - 14-Apr-26 |
| Buy* | 52 | 9.50p | SI Trade |
16:00:29 - 14-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
